|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61P 37/00 |
| (11) | Number of the document | 3348573 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17195757.4 |
| Date of filing the European patent application | 2009-04-24 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 48152 P | 2008-04-25 | US | |
| 48500 P | 2008-04-28 | US |
| (72) |
TENHOOR, Christopher, US
MURUGANANDAM, Arumugam, IN
LADNER, Robert, Charles, US
WOOD, Clive, DE
BITONTI, Alan, J., US
STATTEL, James, US
MCDONNELL, Kevin, US
LIU, Liming, US
DUMONT, Jennifer, US
SATO, Aaron, US
|
| (73) |
Dyax Corp.,
300 Shire Way, Lexington, MA 02421,
US
Bioverativ Therapeutics Inc., 225 2nd Avenue, Waltham, MA 02451, US |
| (54) | METHOD OF PRODUCING ANTIBODIES AGAINST FCRN AND USE THEREOF |
| METHOD OF PRODUCING ANTIBODIES AGAINST FCRN AND USE THEREOF |